Browsing Tag
WuXi AppTec
3 posts
Nano-Mupirocin breakthrough: Revium Rx targets MRSA and VRE with next-generation antibiotic innovation
Find out how Revium Rx’s Nano-Mupirocin could redefine antibiotic therapy against MRSA and VRE and reshape the global antimicrobial resistance market.
LOTTE BIOLOGICS secures third major contract of 2025 through new U.S. biopharma manufacturing deal
LOTTE BIOLOGICS wins a third U.S. contract in 2025, boosting its CDMO momentum and investor sentiment. Find out how the deal shapes biomanufacturing strategy.
NAMSA strengthens its MedTech leadership with WuXi AppTec deal
NAMSA, a global leader in MedTech testing, clinical research, and regulatory consulting, has announced its acquisition of WuXi…